Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Plos One|June 20, 2015
Cellular Adhesion Promotes Prostate Cancer Cells Escape from DormancyNazanin Ruppender, Sandy Larson, Bryce Lakely, et al.
Molecular Cancer Research : MCR|February 12, 2024
Unraveling the Global Proteome and Phosphoproteome of Prostate Cancer Patient-Derived XenograftsZoi E Sychev, Abderrahman Day, Hannah E Bergom, et al.
Nature Communications|March 4, 2021
Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profilingLauren Brady, Michelle Kriner, Ilsa Coleman, et al.
The Journal of Clinical Investigation|February 15, 2021
MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKTTao Shen, Wei Wang, Wolong Zhou, et al.
The Prostate|January 22, 2013
Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastasesSandy R Larson, Xiaotun Zhang, Ruth Dumpit, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 11, 2006
A molecular correlate to the Gleason grading system for prostate adenocarcinomaLawrence True, Ilsa Coleman, Sarah Hawley, et al.
The Journal of Clinical Investigation|November 25, 2010
The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progressionAnkur Sharma, Wen-Shuz Yeow, Adam Ertel, et al.
The Journal of Pathology|August 25, 2021
Reciprocal YAP1 loss and INSM1 expression in neuroendocrine prostate cancerKaushal Asrani, Alba Fc Torres, Juhyung Woo, et al.
Oncotarget|October 11, 2014
Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathwaysLisly Chéry, Hung-Ming Lam, Ilsa Coleman, et al.
Cell Reports|May 28, 2020
Combined TP53 and RB1 Loss Promotes Prostate Cancer Resistance to a Spectrum of Therapeutics and Confers Vulnerability to Replication StressMichael D Nyquist, Alexandra Corella, Ilsa Coleman, et al.
Pageof 10